Trial Profile
Clinical Trials Insight: 700058115
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Aug 2010
Price :
$35
*
At a glance
- Drugs Gatipotuzumab (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- Sponsors Glycotope